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ERRATA
IN THE ARTICLE entitled ‘Socio-economic status and risk of tuberculosis: a case-control study of HIV-
infected patients in Asia’ (Int J Tuberc Lung Dis 2018; 22(2): 179–186, http://dx.doi.org/10.5588/ijtld.17.
0348), the author list should have read as follows:
A. Jiamsakul, M-P. Lee, K. V. Nguyen, T. P. Merati, D. D. Cuong, R. Ditangco, E. Yunihastuti, S.
Ponnampalavanar, F. Zhang, S. Kiertiburanakul, A. Avihingsanon, O. T. Ng, B. L. H. Sim, W-W. Wong, J.
Ross, M. Law
[http://dx.doi.org/10.5588/ijtld.17.0348-e]
IN THE ARTICLE entitled ‘Defining a migrant-inclusive tuberculosis research agenda to end TB)’ (Int J
Tuberc Lung Dis 2018; 22(8): 835–843, http://dx.doi.org/10.5588/ijtld.17.0503), the author names and
affiliations should have read as follows:
P. B. Shete,*† D. Boccia,‡ P. Dhavan,§ N. Gebreselassie,* K. Lo¨nnroth,¶ S. Marks,# A. Matteelli,** D. L.
Posey,†† M. J. van der Werf,‡‡ C. A. Winston,# C. Lienhardt*§§
*Global Tuberculosis Programme,World Health Organization (WHO), Geneva, Switzerland; †Division
of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco,
California, USA; ‡Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical
Medicine, London, UK; §International Organization of Migration, Geneva, Switzerland; ¶Department of
Public Health Sciences, Karolinska Institutet, Stockholm, Sweden; #Division of Tuberculosis Elimination,
Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA; **Department of Infectious
and Tropical Diseases, WHO Collaborating Centre for TB/HIV collaborative activities and for the TB
elimination strategy, University of Brescia, Brescia, Italy; ††Division of Global Quarantine and Migration,
CDC, Atlanta, Georgia, USA; ‡‡European Centre for Disease Prevention and Control, Stockholm,
Sweden; §§Institut de Recherche pour le De´veloppement, Unite´ Mixte de Recherche 233, Montpellier,
France
[http://dx.doi.org/10.5588/ijtld.17.0503-e]
IN THE ARTICLE entitled ‘Droplets, dust and guinea pigs: an historical review of tuberculosis
transmission research, 1878–1940’, (Int J Tuberc Lung Dis 2018; 22(9): 972–982, http://dx.doi.org/10.
5588/ijtld.18.0173), the author list should have read as follows:
P. R. Donald, A. H. Diacon, C. Lange, A-M. Demers, F. von Groote-Bidlingmaier, E. Nardell
[http://dx.doi.org/10.5588/ijtld.18.0173-e]
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